Status:

COMPLETED

Satisfaction and QUality of Life After Breast REconstruction

Lead Sponsor:

Institut Cancerologie de l'Ouest

Conditions:

Mammaplasty

Breast Neoplasm Female

Eligibility:

FEMALE

18+ years

Brief Summary

Breast cancer is the most common cancer in women in France in term of repercussion, 58 698 people has been diagnosed in 2017. Breast cancer is often with good prognosis. The 5 years disease-free survi...

Detailed Description

This study is retrospective and compared including exhaustively all the patients answering all inclusion criteria. The list of patients answering to all inclusion criteria will be collected with the h...

Eligibility Criteria

Inclusion

  • Patients 18 years old or more
  • History of mastectomy for breast cancer all types and TNM status
  • Patients who beneficiated a breast reconstruction immediate or secondary finished between 01/01/2015 and 31/12/16 (not included nipples)
  • Accept to answer to the questionnaire

Exclusion

  • Deceased patient
  • Opposition of the patient to the data collection
  • History of preventive mastectomy
  • Patient who has local recurrence or metastatic cancer
  • Patient under guardianship or protection of vulnerable adults

Key Trial Info

Start Date :

September 3 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 25 2019

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT04329819

Start Date

September 3 2019

End Date

November 25 2019

Last Update

April 1 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut de Cancerologie de l'Ouest

Saint-Herblain, France, 44805